Total (n = 192)

Transfer (n = 38)

Non-Transfer (n = 154)

p value

Demographic Data

Age (median, IQR)

80 [66 - 86]

67 [60.5 - 80.75]

81 [68 - 87]

0.0008

Gender (Men/Women) %

96/96

22/16

74/80

0.3651

Functional Status and Medical History

Barthel Index (median, IQR)

100 [78.75 - 100]

100 [96.25 - 100]

100 [66.25 - 100]

0.0193

Barthel Index < 60

30

1

29

0.0268

mRankin (median, IQR)

0 [0 - 2]

0 [0 - 1]

0 [0 - 3]

0.0284

mRankin ≤ 1

135

32

103

0.0465

Charlson Index (mean, SD)

4.45 (2.14)

3.89

4.58

0.0791

Smoke

33

9

24

0.3809

Hypertension

126

22

104

0.3526

Diabetes mellitus

47

10

37

0.9336

Dyslipidemia

74

16

58

0.7506

Cognitive impairment

40

4

36

0.1275

Atrial fibrillation

42

9

33

0.9345

Mitral valvulopathy

22

3

19

0.5764

Peripheral arteriopathy

13

0

13

0.0752

Ischemic cardiopathy

18

3

15

0.9999

acetylsalicylic acid 100 mg

53

9

44

0.6884

acetylsalicylic acid 300 mg

9

1

8

0.6911

P2Y12 inhibitors

14

1

13

0.3096

Vitamin K inhibitors

22

5

17

0.7763

Direct oral anticoagulants

7

3

4

0.1408

Angiotensin II converting enzyme inhibitors

47

6

41

0.2378

Angiotensin II receptor antagonists

19

5

14

0.5426

Lipid-lowering drugs

60

13

47

0.8070